CanSino: Net profit turned profitable in 2025, reaching 27.87 million yuan, thanks to revenue growth and cost control

LightningPacketLoss · 2026-03-05T20:31:44+00:00

CanSino recently announced that for the year 2025, the total operating revenue is approximately 1.068 billion yuan, a year-on-year increase of 26.18%; net profit attributable to the parent company is approximately 27.87 million yuan, turning a loss into a profit. This is attributed to revenue growth and effective cost control measures.

LightningPacketLoss

2026-03-05 20:31:44

Abstract generation in progress

Recently, CanSino Biologics announced that its 2025 performance quick report shows the company achieved a total operating revenue of approximately 1.068 billion yuan, a year-on-year increase of 26.18%; net profit attributable to shareholders of the parent company was about 27.87 million yuan, successfully turning losses into profits.

The announcement pointed out that the company’s operating profit and total profit both turned profitable, mainly due to the growth in total operating revenue and the effective implementation of cost control measures.

(CanSino Announcement)

(Edited by: Yang Yan, Lin Chen)

Keywords: Healthcare

View Original

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.

1 Likes